Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Meloni

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Diabetes|December 22, 2011
Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic miceMarco Meloni, Betty Descamps, Andrea Caporali, et al.
Vascular|May 30, 2024
Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed antegrade approachMarco Nezzo, Marco Meloni, Alessandro Carini, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcerMarco Meloni, Laura Giurato, Valentina Izzo, et al.
Journal of Diabetes Research|September 6, 2019
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot InfectionMarco Meloni, Valentina Izzo, Laura Giurato, et al.
Circulation Research|May 29, 2010
Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemiaAyman Al Haj Zen, Atsuhiko Oikawa, Miriam Bazan-Peregrino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Barriers to diabetic foot management in Italy: A multicentre survey in diabetic foot centres of the Diabetic Foot Study Group of the Italian Society of Diabetes (SID) and Association of Medical Diabetologists (AMD)Marco Meloni, Silvia Acquati, Carmelo Licciardello, et al.
The International Journal of Lower Extremity Wounds|April 17, 2026
Ulcer Recurrence Impairs Outcomes of Patients with Diabetic FootMartina Salvi, Marco Meloni, Federico Rolando Bonanni, et al.
Current Opinion in Pharmacology|December 27, 2021
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseasesAikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, et al.
Cardiovascular Research|October 23, 2012
Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in miceAgnieszka Jazwa, Jacek Stepniewski, Martin Zamykal, et al.
International Journal of Molecular Sciences|July 13, 2024
Nanomedicine in the Treatment of DiabetesAikaterini Andreadi, Pietro Lodeserto, Federica Todaro, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Diabetes|December 22, 2011
Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic miceMarco Meloni, Betty Descamps, Andrea Caporali, et al.
Vascular|May 30, 2024
Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed antegrade approachMarco Nezzo, Marco Meloni, Alessandro Carini, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcerMarco Meloni, Laura Giurato, Valentina Izzo, et al.
Journal of Diabetes Research|September 6, 2019
Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot InfectionMarco Meloni, Valentina Izzo, Laura Giurato, et al.
Circulation Research|May 29, 2010
Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemiaAyman Al Haj Zen, Atsuhiko Oikawa, Miriam Bazan-Peregrino, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Barriers to diabetic foot management in Italy: A multicentre survey in diabetic foot centres of the Diabetic Foot Study Group of the Italian Society of Diabetes (SID) and Association of Medical Diabetologists (AMD)Marco Meloni, Silvia Acquati, Carmelo Licciardello, et al.
The International Journal of Lower Extremity Wounds|April 17, 2026
Ulcer Recurrence Impairs Outcomes of Patients with Diabetic FootMartina Salvi, Marco Meloni, Federico Rolando Bonanni, et al.
Current Opinion in Pharmacology|December 27, 2021
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseasesAikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, et al.
Cardiovascular Research|October 23, 2012
Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in miceAgnieszka Jazwa, Jacek Stepniewski, Martin Zamykal, et al.
International Journal of Molecular Sciences|July 13, 2024
Nanomedicine in the Treatment of DiabetesAikaterini Andreadi, Pietro Lodeserto, Federica Todaro, et al.
Pageof 15